Law360, New York ( June 3, 2016, 11:15 AM EDT) -- On May 4, 2016, the Third Circuit affirmed a summary judgment finding that Sanofi-Aventis U.S. LLC's loyalty discounts for its anticoagulant drug Lovenox were not anti-competitive. In doing so, the court distinguished several of its earlier opinions and provided some guidance on when these common marketing programs violate the antitrust laws. The plaintiff, Eisai Inc., has requested a rehearing; as long as the opinion stands, however, it has implications for future judicial reviews of loyalty discounts....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.